Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer

Oncogene

Volumn 29, Issue 14, 2010, Pages 2153-2159

  Peng, S ^a,b   Maihle, N J ^a   Huang, Y ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central South University   (China)

Author keywords

Cancer stem cell; Gene therapy; Lin28; Molecular diagnostics; Oct4; Ovarian cancer

Indexed keywords

LIN28 PROTEIN; MESSENGER RNA; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CELL GROWTH; CELL SURVIVAL; CELLULAR DISTRIBUTION; EMBRYONIC STEM CELL; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA TRANSLATION; SOMATIC CELL;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; PHENOTYPE; RNA-BINDING PROTEINS; STEM CELLS;

EID: 77950794030     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.500     Document Type: Article

References (34)

1. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T et al. (2009). Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8: 158-166.
2. Assou S, Cerecedo D, Tondeur S, Pantesco V, Hovatta O, Klein B et al. (2009). A gene expression signature shared by human mature oocytes and embryonic stem cells. BMC Genomics 10: 10. (doi:10.1186/1471-2164-10-10).
3. Benard J, Da Silva J, De Blois M-C, Boyer P, Duvillard P, Chiric E et al. (1985). Characterization of a human ovarian adenocarcinoma Line, IGROV1, in tissue culture and in nude mice. Cancer Research 45: 4970-4979.
4. Bussing I, Slack FJ, Gro-Hans H. (2008). Let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 14: 400-409.
5. Chen Z, Xu W, Qian H, Zhu W, Bu X, Wang S et al. (2009). Oct4, a novel marker for human gastric cancer. J Surg Onco 99: 414-419.
6. Cheng L, Sung M-T, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J et al. (2007). OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211: 1-9.
7. Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM et al. (2009). Raf kinase inhibitory protein suppresses a metastasis signaling cascade involving LIN28 and let-7. EMBO J 28: 347-358.
8. Darr H, Benvenisty N. (2008). Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells 27: 352-362.
9. Fodde R. (2009). The stem of cancer. Cancer Cell 15: 87-89.
10. Heo I, Joo C, Cho J, Ha M, Han J, Kim NV. (2008). Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Mol Cell 32: 276-284.
11. Heo I, Joo C, Kim YK, Ha M, Yoon MJ, Cho J et al. (2009). TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA Uridylation. Cell 138: 696-708.
12. Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S. (2008). Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 68: 6533-6540.
13. Jinawath N, Vasoontara C, Yap K-L, Thiaville MM, Nakayama K, Wang T-L et al. (2009). NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway. Oncogene 28: 1941-1948.
14. Jordan CT. (2009). Cancer stem cells: controversial or just misunderstood? Cell Stem Cell 4: 203-205.
15. Lu L, Katsaros D, Shaverdashvili K, Qian B, Wu Y, de la Longrais IA et al. (2009). Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer 45: 2212-2218.
16. Marotta LL, Polyak K. (2009). Cancer stem cells: a model in the making. Curr Opin Genet Dev 19: 44-50.
17. Moss EG, Lee RC, Ambros V. (1997). The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88: 637-646.
18. Moss EG, Tang L. (2003). Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev Biol 258: 432-442.
19. Newman MA, Thomson JM, Hammond SM. (2008). Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14: 1539-1549.
20. Pei D. (2009). Regulation of pluripotency and reprogramming by transcription factors. J Biol Chem 284: 3365-3369.
21. Polesskaya A, Cuvellier S, Naguibneva I, Duquet A, Moss EG, Harel- Bellan A. (2007). Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev 21: 1125-1138.
22. Qiu C, Ma Y, Wang J, Peng S, Huang Y. (2009). Lin28-mediated posttranscriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res (doi:10.1093/nar/gkp1071).
23. Richard M, Tan SP, Tan JH, Chan WK, Bongso A. (2004). The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22: 51-64. (Pubitemid 38018781)
24. Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, Nitsch R et al. (2008). A feedback loop comprising lin-28 and let-7 controls pre-let- 7 maturation during neural stem-cell commitment. Nat Cell Biol 10: 987-993.
25. Trabucchi M, Briata P, Carcia-Mayoral M, Haase AD, Filipowicz W, Ramos A et al. (2009). The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459: 1010-1014.
26. Vasey PA. (2008). Ovarian cancer: front-line standard treatment in 2008. Ann Oncol 19(Suppl 7): vii61-vii66.
27. Viswanathan SR, Daley GQ, Gregory RI. (2008). Selective blockade of microRNA processing by Lin-28. Science 320: 97-100.
28. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S et al. (2009). Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 41: 843-848.
29. Xu B, Huang Y. (2009). Histone H2a mRNA interacts with Lin28 and contains a Lin28-dependent posttranscriptional regulatory element. Nucleic Acids Res 37: 4256-4263.
30. Xu B, Zhang K, Huang Y. (2009). Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells. RNA 15: 357-361.
31. Yang DH, Moss EG. (2003). Temporally regulated expression of Lin- 28 in diverse tissues of the developing mouse. Gene Expr Patterns 3: 719-726.
32. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S. et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
33. Zhang K, Wang Q, Xie Y, Mor G, Sega E, Low PS et al. (2008). Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions. RNA 14: 577-583.
34. Zhang M, Guller S, Huang Y. (2007). Method to enhance transfection efficiency of cell lines and placental fibroblasts. Placenta 28: 779-782.